Brokerages Expect AMETEK, Inc. (AME) Will Post Earnings of $0.78 Per Share

Share on StockTwits

Wall Street analysts expect AMETEK, Inc. (NYSE:AME) to announce earnings per share (EPS) of $0.78 for the current quarter, according to Zacks Investment Research. Six analysts have issued estimates for AMETEK’s earnings, with the lowest EPS estimate coming in at $0.78 and the highest estimate coming in at $0.80. AMETEK reported earnings per share of $0.66 during the same quarter last year, which suggests a positive year-over-year growth rate of 18.2%. The business is expected to issue its next quarterly earnings results before the market opens on Thursday, November 1st.

According to Zacks, analysts expect that AMETEK will report full-year earnings of $3.21 per share for the current fiscal year, with EPS estimates ranging from $3.19 to $3.24. For the next fiscal year, analysts forecast that the firm will report earnings of $3.53 per share, with EPS estimates ranging from $3.44 to $3.61. Zacks Investment Research’s EPS calculations are an average based on a survey of analysts that follow AMETEK.

AMETEK (NYSE:AME) last issued its quarterly earnings results on Tuesday, July 31st. The technology company reported $0.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.78 by $0.05. AMETEK had a return on equity of 16.94% and a net margin of 16.65%. The company had revenue of $1.21 billion for the quarter, compared to analysts’ expectations of $1.19 billion. During the same period last year, the firm earned $0.65 EPS. The firm’s revenue for the quarter was up 13.6% on a year-over-year basis.

A number of brokerages recently issued reports on AME. ValuEngine cut AMETEK from a “buy” rating to a “hold” rating in a report on Tuesday, October 23rd. BMO Capital Markets lifted their target price on AMETEK from $92.00 to $93.00 and gave the stock an “outperform” rating in a report on Wednesday, August 1st. Oppenheimer lifted their target price on AMETEK from $85.00 to $90.00 and gave the stock an “outperform” rating in a report on Wednesday, August 1st. Morgan Stanley lifted their target price on AMETEK from $79.00 to $84.00 and gave the stock an “equal weight” rating in a report on Wednesday, August 1st. Finally, Cowen restated a “buy” rating and issued a $85.00 target price on shares of AMETEK in a report on Sunday, August 12th. Three equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average target price of $86.83.

In other news, Director Elizebeth R. Varet sold 2,000 shares of the firm’s stock in a transaction on Tuesday, July 31st. The stock was sold at an average price of $76.95, for a total value of $153,900.00. Following the completion of the sale, the director now owns 113,810 shares of the company’s stock, valued at $8,757,679.50. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Elizebeth R. Varet sold 3,000 shares of the firm’s stock in a transaction on Tuesday, August 7th. The stock was sold at an average price of $76.95, for a total value of $230,850.00. Following the completion of the sale, the director now directly owns 113,810 shares of the company’s stock, valued at approximately $8,757,679.50. The disclosure for this sale can be found here. In the last ninety days, insiders sold 61,925 shares of company stock valued at $4,965,110. 2.00% of the stock is currently owned by insiders.

Institutional investors have recently modified their holdings of the company. Fjarde AP Fonden Fourth Swedish National Pension Fund lifted its stake in AMETEK by 1.0% in the second quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 73,586 shares of the technology company’s stock valued at $5,310,000 after buying an additional 702 shares during the last quarter. BB&T Securities LLC grew its stake in AMETEK by 10.9% during the 2nd quarter. BB&T Securities LLC now owns 7,908 shares of the technology company’s stock valued at $570,000 after purchasing an additional 779 shares in the last quarter. Riverhead Capital Management LLC grew its stake in AMETEK by 9.9% during the 2nd quarter. Riverhead Capital Management LLC now owns 9,293 shares of the technology company’s stock valued at $670,000 after purchasing an additional 836 shares in the last quarter. Intrust Bank NA lifted its holdings in AMETEK by 10.8% during the 2nd quarter. Intrust Bank NA now owns 8,994 shares of the technology company’s stock worth $649,000 after buying an additional 880 shares during the last quarter. Finally, Neuburgh Advisers LLC lifted its holdings in AMETEK by 12.1% during the 2nd quarter. Neuburgh Advisers LLC now owns 8,162 shares of the technology company’s stock worth $589,000 after buying an additional 880 shares during the last quarter. 85.13% of the stock is owned by institutional investors and hedge funds.

Shares of AME stock traded down $0.05 during mid-day trading on Monday, hitting $66.73. 15,743 shares of the stock traded hands, compared to its average volume of 1,426,838. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.19 and a current ratio of 1.71. The stock has a market cap of $15.47 billion, a PE ratio of 25.77, a price-to-earnings-growth ratio of 1.90 and a beta of 1.18. AMETEK has a twelve month low of $65.22 and a twelve month high of $81.92.

AMETEK Company Profile

AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices worldwide. Its Electronic Instruments Group segment offers advanced instruments for the process, power and industrial, and aerospace markets; process and analytical instruments for the oil, gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage markets; and instruments for the laboratory equipment, ultraprecision manufacturing, medical, and test and measurement markets.

See Also: New Google Finance Tool and Screening Stocks

Get a free copy of the Zacks research report on AMETEK (AME)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for AMETEK (NYSE:AME)

Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.